An expert panel of India's drug regulator has recommended vaccine maker Bharat Biotech's Covid-19 shot for emergency use in children aged 2 to 18 years, making it the first vaccine in the country to get approval for use in kids below 12 years, according to Reuters.
Bharat Biotech's data from clinical trials for Covaxin in the age-group “has been thoroughly reviewed by the Central Drugs Standard Control Organisation and Subject Expert Committee and (they) have provided their positive recommendations,” the vaccine maker told Reuters in a statement.
